Seattle, WA · Founded 2008 · Privately Held (backing)
Developer of a synthetic biology technology designed to create new designer proteins and enzymes with less risk. Arzeda is based in Seattle, WA and was founded in 2008. It was valued at $150 million at its later-stage round in Dec 2025, the last priced event on record. It has raised $109 million across 6 recorded rounds; the latest was a $4.5 million seed round in Aug 2025.
PMV mark · valuation
$149.5M
Oct 2026
Priced at
its later-stage round
Dec 2025
Total raised
$109.2M
Last round
Seed Round
Aug 2025
Cap table — not yet on record
Arzeda's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Arzeda with a free account
·The complete investor list: 25 names
·Watch Arzeda: the Monday email on marks, rounds and moves